614 related articles for article (PubMed ID: 34016183)
1. Genetic susceptibility of COVID-19: a systematic review of current evidence.
SeyedAlinaghi S; Mehrtak M; MohsseniPour M; Mirzapour P; Barzegary A; Habibi P; Moradmand-Badie B; Afsahi AM; Karimi A; Heydari M; Mehraeen E; Dadras O; Sabatier JM; Voltarelli F
Eur J Med Res; 2021 May; 26(1):46. PubMed ID: 34016183
[TBL] [Abstract][Full Text] [Related]
2. Polymorphisms and mutations of ACE2 and TMPRSS2 genes are associated with COVID-19: a systematic review.
Li J; Wang Y; Liu Y; Zhang Z; Zhai Y; Dai Y; Wu Z; Nie X; Du L
Eur J Med Res; 2022 Feb; 27(1):26. PubMed ID: 35193695
[TBL] [Abstract][Full Text] [Related]
3. Genetic polymorphisms of ACE1, ACE2, and TMPRSS2 associated with COVID-19 severity: A systematic review with meta-analysis.
Saengsiwaritt W; Jittikoon J; Chaikledkaew U; Udomsinprasert W
Rev Med Virol; 2022 Jul; 32(4):e2323. PubMed ID: 34997794
[TBL] [Abstract][Full Text] [Related]
4. ACE2 and TMPRSS2 polymorphisms in various diseases with special reference to its impact on COVID-19 disease.
Singh H; Choudhari R; Nema V; Khan AA
Microb Pathog; 2021 Jan; 150():104621. PubMed ID: 33278516
[TBL] [Abstract][Full Text] [Related]
5. The contrasting role of nasopharyngeal angiotensin converting enzyme 2 (ACE2) transcription in SARS-CoV-2 infection: A cross-sectional study of people tested for COVID-19 in British Columbia, Canada.
Nikiforuk AM; Kuchinski KS; Twa DDW; Lukac CD; Sbihi H; Basham CA; Steidl C; Prystajecky NA; Jassem AN; Krajden M; Patrick DM; Sekirov I
EBioMedicine; 2021 Apr; 66():103316. PubMed ID: 33819740
[TBL] [Abstract][Full Text] [Related]
6. Nasopharyngeal Expression of Angiotensin-Converting Enzyme 2 and Transmembrane Serine Protease 2 in Children within SARS-CoV-2-Infected Family Clusters.
Hasan MR; Ahmad MN; Dargham SR; Zayed H; Al Hashemi A; Ngwabi N; Perez Lopez A; Dobson S; Abu Raddad LJ; Tang P
Microbiol Spectr; 2021 Dec; 9(3):e0078321. PubMed ID: 34730438
[TBL] [Abstract][Full Text] [Related]
7. ACE2 polymorphism and susceptibility for SARS-CoV-2 infection and severity of COVID-19.
Möhlendick B; Schönfelder K; Breuckmann K; Elsner C; Babel N; Balfanz P; Dahl E; Dreher M; Fistera D; Herbstreit F; Hölzer B; Koch M; Kohnle M; Marx N; Risse J; Schmidt K; Skrzypczyk S; Sutharsan S; Taube C; Westhoff TH; Jöckel KH; Dittmer U; Siffert W; Kribben A
Pharmacogenet Genomics; 2021 Oct; 31(8):165-171. PubMed ID: 34001841
[TBL] [Abstract][Full Text] [Related]
8. Sex-related susceptibility in coronavirus disease 2019 (COVID-19): Proposed mechanisms.
Aksoyalp ZŞ; Nemutlu-Samur D
Eur J Pharmacol; 2021 Dec; 912():174548. PubMed ID: 34606834
[TBL] [Abstract][Full Text] [Related]
9. Bioinformatics Analysis of Allele Frequencies and Expression Patterns of ACE2, TMPRSS2 and FURIN in Different Populations and Susceptibility to SARS-CoV-2.
Tarek M; Abdelzaher H; Kobeissy F; El-Fawal HAN; Salama MM; Abdelnaser A
Genes (Basel); 2021 Jul; 12(7):. PubMed ID: 34356057
[TBL] [Abstract][Full Text] [Related]
10. Genetic Susceptibility of ACE2 and TMPRSS2 in Six Common Cancers and Possible Impacts on COVID-19.
Hoang T; Nguyen TQ; Tran TTA
Cancer Res Treat; 2021 Jul; 53(3):650-656. PubMed ID: 33421977
[TBL] [Abstract][Full Text] [Related]
11. ACE2, TMPRSS2, and Furin variants and SARS-CoV-2 infection in Madrid, Spain.
Torre-Fuentes L; Matías-Guiu J; Hernández-Lorenzo L; Montero-Escribano P; Pytel V; Porta-Etessam J; Gómez-Pinedo U; Matías-Guiu JA
J Med Virol; 2021 Feb; 93(2):863-869. PubMed ID: 32691890
[TBL] [Abstract][Full Text] [Related]
12.
Abdelsattar S; Kasemy ZA; Ewida SF; Abo-Elsoud RAA; Zytoon AA; Abdelaal GA; Abdelgawad AS; Khalil FO; Kamel HFM
Br J Biomed Sci; 2022; 79():10238. PubMed ID: 35996506
[No Abstract] [Full Text] [Related]
13. Gender susceptibility to COVID-19: a review of the putative role of sex hormones and X chromosome.
Foresta C; Rocca MS; Di Nisio A
J Endocrinol Invest; 2021 May; 44(5):951-956. PubMed ID: 32936429
[TBL] [Abstract][Full Text] [Related]
14. Assessing COVID-19 susceptibility through analysis of the genetic and epigenetic diversity of ACE2-mediated SARS-CoV-2 entry.
Ragia G; Manolopoulos VG
Pharmacogenomics; 2020 Dec; 21(18):1311-1329. PubMed ID: 33243086
[TBL] [Abstract][Full Text] [Related]
15. Co-Expression and Localization of Angiotensin-Converting Enzyme-2 (ACE2) and the Transmembrane Serine Protease 2 (TMPRSS2) in Paranasal Ciliated Epithelium of Patients with Chronic Rhinosinusitis.
Kawasumi T; Takeno S; Ishino T; Ueda T; Hamamoto T; Takemoto K; Horibe Y; Takashi O
Am J Rhinol Allergy; 2022 May; 36(3):313-322. PubMed ID: 34989246
[TBL] [Abstract][Full Text] [Related]
16. Characteristics of Angiotensin I-converting enzyme 2, type II transmembrane serine protease 2 and 4 in tree shrew indicate it as a potential animal model for SARS-CoV-2 infection.
Li N; Gu W; Lu C; Sun X; Tong P; Han Y; Wang W; Dai J
Bioengineered; 2021 Dec; 12(1):2836-2850. PubMed ID: 34227905
[TBL] [Abstract][Full Text] [Related]
17. Expression profile of SARS-CoV-2 cellular entry proteins in normal oral mucosa and oral squamous cell carcinoma.
Sapkota D; Sharma S; Søland TM; Braz-Silva PH; Teh MT
Clin Exp Dent Res; 2022 Feb; 8(1):117-122. PubMed ID: 34726347
[TBL] [Abstract][Full Text] [Related]
18. Systematic analysis of ACE2 and TMPRSS2 expression in salivary glands reveals underlying transmission mechanism caused by SARS-CoV-2.
Song J; Li Y; Huang X; Chen Z; Li Y; Liu C; Chen Z; Duan X
J Med Virol; 2020 Nov; 92(11):2556-2566. PubMed ID: 32441816
[TBL] [Abstract][Full Text] [Related]
19. Variants in ACE2 and TMPRSS2 Genes Are Not Major Determinants of COVID-19 Severity in UK Biobank Subjects.
Curtis D
Hum Hered; 2020; 85(2):66-68. PubMed ID: 33752217
[TBL] [Abstract][Full Text] [Related]
20. Human genetic basis of coronavirus disease 2019.
Deng H; Yan X; Yuan L
Signal Transduct Target Ther; 2021 Sep; 6(1):344. PubMed ID: 34545062
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
